Extra caution is advised in people with: A history of pancreatitis Severe acidity or gastroparesis (very slow stomach emptying) Known gallstones or gallbladder disease Advanced kidney disease Significant diabetic eye disease (retinopathy) A very low BMI or a history of eating disorders Pregnancy, plans to become pregnant, or breastfeeding, since some GLP-1 medicines stay in the body for several weeks after stopping Significant depression, who should be monitored carefully Upcoming surgery, endoscopy, or a procedure needing anaesthesia or sedation, since delayed stomach emptying can raise aspiration risk and temporary stopping may be advised How GLP-1 side effects usually progress: a typical timeline Every person is different, but clinical practice and studies suggest a rough pattern [6]: First 2 to 6 weeks: nausea, early fullness, and constipation are most common

Despite their popularity on social media, these medications carry significant risks and can be harmful to those who do not need them
These brain regions all sense signals communicated via the gut-brain axis networkand scientists have found they are studded with GLP-1 receptors
The key question may not be whether GLP-1 therapy is inherently harmful to bone health, but rather how we can identify and support those patients who significantly reduce their food intake during treatment
Extreme genome reduction in symbiotic bacteria